Literature DB >> 15927257

Erythropoietin: a novel neuroprotective cytokine.

Stefano Bartesaghi1, Marina Marinovich, Emanuela Corsini, Corrado L Galli, Barbara Viviani.   

Abstract

Erythropoietin (Epo), the principal regulator of erythroids progenitor cells, greatly improves neuronal survival. A wide variety of experimental studies have shown that both Epo and the EpoR are functionally expressed in the nervous system and that this cytokine exerts a remarkable neuroprotection both in vitro against different neurotoxicants and in animal models of nervous system disorders. Aim of this review is to summarize the neuroprotective properties of Epo and to outline the molecular mechanisms involved in order to point out the signal transduction pathway which may represent the potential basis for future strategies against neuronal injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927257     DOI: 10.1016/j.neuro.2005.01.016

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  30 in total

Review 1.  Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

Authors:  Cristina Hernández; Rafael Simó
Journal:  Endocrine       Date:  2011-12-14       Impact factor: 3.633

2.  Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea, and sclera.

Authors:  Ana Paula Resende; Beatriz Silva; Berta São Braz; Telmo Nunes; Lídia Gonçalves; Esmeralda Delgado
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

Review 3.  Molecular and cellular immune mediators of neuroprotection.

Authors:  Nicolas P Turrin; Serge Rivest
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

4.  Decreased VEGF expression and microvascular density, but increased HIF-1 and 2α accumulation and EPO expression in chronic moderate hyperoxia in the mouse brain.

Authors:  Girriso F Benderro; Xiaoyan Sun; Youzhi Kuang; Joseph C Lamanna
Journal:  Brain Res       Date:  2012-07-20       Impact factor: 3.252

5.  Erythropoietin ameliorates the motor and cognitive function impairments in a rat model of hepatic cirrhosis.

Authors:  Iraj Aghaei; Masoud Nazeri; Mohammad Shabani; Marziehsadat Mossavinasab; Fatemeh Khaleghi Mirhosseini; Mohsen Nayebpour; Afshin Dalili
Journal:  Metab Brain Dis       Date:  2014-08-13       Impact factor: 3.584

6.  Alternative route for erythropoietin ocular administration.

Authors:  Ana Paula Resende; Berta São-Braz; Esmeralda Delgado
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-24       Impact factor: 3.117

Review 7.  Do non-hemopoietic effects of erythropoietin play a beneficial role in heart failure?

Authors:  Roberto Latini; Michael Brines; Fabio Fiordaliso
Journal:  Heart Fail Rev       Date:  2008-01-31       Impact factor: 4.214

8.  Upregulation of neurotrophic factor-related gene expression in retina with experimental autoimmune uveoretinitis by intravitreal injection of tacrolimus (FK506).

Authors:  Keiko Oh-i; Hiroshi Keino; Hiroshi Goto; Naoyuki Yamakawa; Masaru Takeuchi; Masahiko Usui; Takuya Iwasaki
Journal:  Br J Ophthalmol       Date:  2007-10-16       Impact factor: 4.638

Review 9.  Erythropoietin in spinal cord injury.

Authors:  Georgios K Matis; Theodossios A Birbilis
Journal:  Eur Spine J       Date:  2008-11-22       Impact factor: 3.134

Review 10.  Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.

Authors:  Tomohiro Chiba; Ikuo Nishimoto; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.